Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02551497Phase 1Completed
Phase 1, randomised, double-blind trial in trigeminal neuralgia (TN) comparing Vixotrigine + Carbamazepine with Placebo + Carbamazepine (2 arms). Primary endpoints: Area Under the Curve, Maximum Plasma Concentration at 5 days and 5 more. Started Apr 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02551497.